NCT00574171 2019-12-18
Phase II Trial of Lapatinib & Capecitabine for Patients With Refractory Advanced Colorectal Adenocarcinoma
University of Wisconsin, Madison
Phase 2 Completed
University of Wisconsin, Madison
Fondazione del Piemonte per l'Oncologia
GlaxoSmithKline